Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma

X. Yu, Y. Zhen, H. Yang, H. Wang, Y. Zhou, E. Wang, F. M. Marincola, C. Mai, Y. Chen, H. Wei, Y. Song, X. Lyu, Y. Ye, L. Cai, Q. Wu, M. Zhao, S. Hua, Q. Fu, Y. Zhang, K. Yao & 3 others Z. Liu, X. Li, W. Fang

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Connective tissue growth factor (CTGF) has different roles in different types of cancer. However, the involvement and molecular basis of CTGF in tumor progression and prognosis of human nasopharyngeal carcinoma (NPC) have almost never been reported. In this study, we observed that downregulated CTGF expression was significantly associated with NPC progression and poor prognosis. Knockdown of CTGF markedly elevated the ability of cell proliferation in vivo and in vitro. Subsequently, we discovered that the reduction of CTGF increased the expression of miR-18b, an oncomir-promoting cell proliferation. Further, we discovered that attenuated CTGF-mediated upregulation of miR-18b was dependent on the increased binding of transcription factors Jun proto-oncogene (C-Jun) and v-Myc myelocytomatosis viral oncogene homolog (C-Myc) to miR-18b promoter region via phosphoinositide 3-kinase (PI3K)/AKT pathway. Finally, we further found that miR-18b directly suppressed the expression of CTGF in NPC. In clinical fresh specimens, miR-18b was widely overexpressed and inversely correlated with CTGF expression in NPC. Our studies are the first to demonstrate that reduced CTGF as an unfavorable prognosis factor mediates the activation of miR-18b, an oncomir directly suppresses CTGF expression, by PI3K/AKT/C-Jun and C-Myc and promotes cell growth of NPC.

Original languageEnglish
Article numbere634
JournalCell Death and Disease
Volume4
Issue number5
DOIs
Publication statusPublished - May 2013
Externally publishedYes

Fingerprint

Connective Tissue Growth Factor
1-Phosphatidylinositol 4-Kinase
Growth
Cell Proliferation
jun Genes
Nasopharyngeal carcinoma
Oncogenes
Genetic Promoter Regions
Neoplasms
Transcription Factors
Up-Regulation
Down-Regulation

Keywords

  • CTGF
  • MiR-18b
  • NPC
  • PI3K/AKT

ASJC Scopus subject areas

  • Immunology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Cancer Research

Cite this

Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma. / Yu, X.; Zhen, Y.; Yang, H.; Wang, H.; Zhou, Y.; Wang, E.; Marincola, F. M.; Mai, C.; Chen, Y.; Wei, H.; Song, Y.; Lyu, X.; Ye, Y.; Cai, L.; Wu, Q.; Zhao, M.; Hua, S.; Fu, Q.; Zhang, Y.; Yao, K.; Liu, Z.; Li, X.; Fang, W.

In: Cell Death and Disease, Vol. 4, No. 5, e634, 05.2013.

Research output: Contribution to journalArticle

Yu, X, Zhen, Y, Yang, H, Wang, H, Zhou, Y, Wang, E, Marincola, FM, Mai, C, Chen, Y, Wei, H, Song, Y, Lyu, X, Ye, Y, Cai, L, Wu, Q, Zhao, M, Hua, S, Fu, Q, Zhang, Y, Yao, K, Liu, Z, Li, X & Fang, W 2013, 'Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma', Cell Death and Disease, vol. 4, no. 5, e634. https://doi.org/10.1038/cddis.2013.153
Yu, X. ; Zhen, Y. ; Yang, H. ; Wang, H. ; Zhou, Y. ; Wang, E. ; Marincola, F. M. ; Mai, C. ; Chen, Y. ; Wei, H. ; Song, Y. ; Lyu, X. ; Ye, Y. ; Cai, L. ; Wu, Q. ; Zhao, M. ; Hua, S. ; Fu, Q. ; Zhang, Y. ; Yao, K. ; Liu, Z. ; Li, X. ; Fang, W. / Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma. In: Cell Death and Disease. 2013 ; Vol. 4, No. 5.
@article{2db89070ef2948698d61cbd47b83c144,
title = "Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma",
abstract = "Connective tissue growth factor (CTGF) has different roles in different types of cancer. However, the involvement and molecular basis of CTGF in tumor progression and prognosis of human nasopharyngeal carcinoma (NPC) have almost never been reported. In this study, we observed that downregulated CTGF expression was significantly associated with NPC progression and poor prognosis. Knockdown of CTGF markedly elevated the ability of cell proliferation in vivo and in vitro. Subsequently, we discovered that the reduction of CTGF increased the expression of miR-18b, an oncomir-promoting cell proliferation. Further, we discovered that attenuated CTGF-mediated upregulation of miR-18b was dependent on the increased binding of transcription factors Jun proto-oncogene (C-Jun) and v-Myc myelocytomatosis viral oncogene homolog (C-Myc) to miR-18b promoter region via phosphoinositide 3-kinase (PI3K)/AKT pathway. Finally, we further found that miR-18b directly suppressed the expression of CTGF in NPC. In clinical fresh specimens, miR-18b was widely overexpressed and inversely correlated with CTGF expression in NPC. Our studies are the first to demonstrate that reduced CTGF as an unfavorable prognosis factor mediates the activation of miR-18b, an oncomir directly suppresses CTGF expression, by PI3K/AKT/C-Jun and C-Myc and promotes cell growth of NPC.",
keywords = "CTGF, MiR-18b, NPC, PI3K/AKT",
author = "X. Yu and Y. Zhen and H. Yang and H. Wang and Y. Zhou and E. Wang and Marincola, {F. M.} and C. Mai and Y. Chen and H. Wei and Y. Song and X. Lyu and Y. Ye and L. Cai and Q. Wu and M. Zhao and S. Hua and Q. Fu and Y. Zhang and K. Yao and Z. Liu and X. Li and W. Fang",
year = "2013",
month = "5",
doi = "10.1038/cddis.2013.153",
language = "English",
volume = "4",
journal = "Cell Death and Disease",
issn = "2041-4889",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma

AU - Yu, X.

AU - Zhen, Y.

AU - Yang, H.

AU - Wang, H.

AU - Zhou, Y.

AU - Wang, E.

AU - Marincola, F. M.

AU - Mai, C.

AU - Chen, Y.

AU - Wei, H.

AU - Song, Y.

AU - Lyu, X.

AU - Ye, Y.

AU - Cai, L.

AU - Wu, Q.

AU - Zhao, M.

AU - Hua, S.

AU - Fu, Q.

AU - Zhang, Y.

AU - Yao, K.

AU - Liu, Z.

AU - Li, X.

AU - Fang, W.

PY - 2013/5

Y1 - 2013/5

N2 - Connective tissue growth factor (CTGF) has different roles in different types of cancer. However, the involvement and molecular basis of CTGF in tumor progression and prognosis of human nasopharyngeal carcinoma (NPC) have almost never been reported. In this study, we observed that downregulated CTGF expression was significantly associated with NPC progression and poor prognosis. Knockdown of CTGF markedly elevated the ability of cell proliferation in vivo and in vitro. Subsequently, we discovered that the reduction of CTGF increased the expression of miR-18b, an oncomir-promoting cell proliferation. Further, we discovered that attenuated CTGF-mediated upregulation of miR-18b was dependent on the increased binding of transcription factors Jun proto-oncogene (C-Jun) and v-Myc myelocytomatosis viral oncogene homolog (C-Myc) to miR-18b promoter region via phosphoinositide 3-kinase (PI3K)/AKT pathway. Finally, we further found that miR-18b directly suppressed the expression of CTGF in NPC. In clinical fresh specimens, miR-18b was widely overexpressed and inversely correlated with CTGF expression in NPC. Our studies are the first to demonstrate that reduced CTGF as an unfavorable prognosis factor mediates the activation of miR-18b, an oncomir directly suppresses CTGF expression, by PI3K/AKT/C-Jun and C-Myc and promotes cell growth of NPC.

AB - Connective tissue growth factor (CTGF) has different roles in different types of cancer. However, the involvement and molecular basis of CTGF in tumor progression and prognosis of human nasopharyngeal carcinoma (NPC) have almost never been reported. In this study, we observed that downregulated CTGF expression was significantly associated with NPC progression and poor prognosis. Knockdown of CTGF markedly elevated the ability of cell proliferation in vivo and in vitro. Subsequently, we discovered that the reduction of CTGF increased the expression of miR-18b, an oncomir-promoting cell proliferation. Further, we discovered that attenuated CTGF-mediated upregulation of miR-18b was dependent on the increased binding of transcription factors Jun proto-oncogene (C-Jun) and v-Myc myelocytomatosis viral oncogene homolog (C-Myc) to miR-18b promoter region via phosphoinositide 3-kinase (PI3K)/AKT pathway. Finally, we further found that miR-18b directly suppressed the expression of CTGF in NPC. In clinical fresh specimens, miR-18b was widely overexpressed and inversely correlated with CTGF expression in NPC. Our studies are the first to demonstrate that reduced CTGF as an unfavorable prognosis factor mediates the activation of miR-18b, an oncomir directly suppresses CTGF expression, by PI3K/AKT/C-Jun and C-Myc and promotes cell growth of NPC.

KW - CTGF

KW - MiR-18b

KW - NPC

KW - PI3K/AKT

UR - http://www.scopus.com/inward/record.url?scp=84879384573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879384573&partnerID=8YFLogxK

U2 - 10.1038/cddis.2013.153

DO - 10.1038/cddis.2013.153

M3 - Article

VL - 4

JO - Cell Death and Disease

JF - Cell Death and Disease

SN - 2041-4889

IS - 5

M1 - e634

ER -